References
- Soonpaa MH, Field LJ. Assessment of cardiomyocyte DNA synthesis in normal and injured adult mouse hearts. Am J Physiol 1997; 272: 220-6
- Pasumarthi KB, Field LJ. Cardiomyocyte cell cycle regulation. Circ Res. 2002 May 31; 90: 1044-54
- Rubart M, Field LJ. Cardiac regeneration: repopulating the heart. Annu Rev Physiol 2006; 68: 29-49 https://doi.org/10.1146/annurev.physiol.68.040104.124530
- Zimmermann WH, Eschenhagen T. Embryonic stem cells for cardiac muscle engineering. Trends Cardiovasc Med 2007; 17: 134-40 https://doi.org/10.1016/j.tcm.2007.02.007
- Dirnmeler S, Zeiher AM, Schneider MD. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 2005; 115: 572-83 https://doi.org/10.1172/JCI200524283
- Murry CE, Field LJ, Menasche P. Cell-based cardiac repair: reflections at the 10-year point. Circulation 2005; 15: 3174-83
- Friedenstein AJ, Piatetzky-Shapiro II, Petrakova KV. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 1966; 16: 381-90
- Prindull G, Prindull B, Meulen N. Haematopoietic stem cells (CFUc) in human cord blood 1978; 67: 413-6
- Zvaifler NJ, Marinova-Mutafchieva L, Adams G, Edwards CJ, Moss J, Burger JA, et al. Mesecnchymal precursor cells in the blood of normal individuals. Arthritis Res 2000; 2: 477-88 https://doi.org/10.1186/ar130
- Zuk PA, ZhuM, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13: 4279-95 https://doi.org/10.1091/mbc.E02-02-0105
- Toda A, Okabe M, Yoshida T, Nikaido T. The potential of amniotic membrane/amnion-derived cells for regeneration of various tissues. J Pharmacol Sci 2007; 105: 215-28 https://doi.org/10.1254/jphs.CR0070034
- In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, Noort WA, Claas FH, Willernze R, et al. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 2003; 102: 1548-9 https://doi.org/10.1182/blood-2003-04-1291
- Romanov YA, Svintsitskaya VA, Smirnov VN. Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 2003; 21: 105-10 https://doi.org/10.1634/stemcells.21-1-105
- Fukuchi Y, Nakajima H, Sugiyama D, Hirose I, Kitamura T, Tsuji K. Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells 2004; 225: 649-58
- He JQ, Ma Y, Lee Y, Thomson JA, Karnp TJ. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res 2003; 93: 32-9 https://doi.org/10.1161/01.RES.0000080317.92718.99
- Leor J, Gerecht S, Cohen S, Miller L, Holbova R, Ziskind A, et al. Human embryonic stem cell transplantation to repair the infarcted myocardium. Heart 2007; 93: 1278-84 https://doi.org/10.1136/hrt.2006.093161
- Xu C, Police S, Rao N, Carpenter MK. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res 2002; 9: 501-8
- Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK, et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007; 25: 1015-24 https://doi.org/10.1038/nbt1327
- Xu W, Zhang X, Qian H. Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Exp Biol Med 2004; 229: 623-31 https://doi.org/10.1177/153537020422900706
- Kadivar M, Khatami S, Mortazavi Y, Shokrgozar MA, Taghikhani M, Soleimani M. In vitro cardiomyogenic potential of human umbilical vein-derived mesenchymal stem cells. Bio Chem Biophys Res Commun 2006; 340: 639-47 https://doi.org/10.1016/j.bbrc.2005.12.047
- Balana B, Nicoletti C, Zahanich I, Graf EM, Christ T, Boxberger S, et al. 5-Azacytidine induces changes in electrophysiological properties of human mesenchymal stem cells. Cell Res 2006; 16: 949-60 https://doi.org/10.1038/sj.cr.7310116
- Zhao P, Ise H, Hongo M, Ota M, Konishi I, Nikaido T. Human amniotic mesenchymal cells have some characteristics of cardiomyocytes. Transplantation 2005; 79: 528-35 https://doi.org/10.1097/01.TP.0000149503.92433.39
- Shim WS, Jiang S, Wong P, Tan J, Chua YL, Tan YS, et at. Ex vivo differentiation of human adult bone marrow stem cells into cardiomyocyte-like cells. Biochem Biophys Res Commun 2004; 324: 481-8 https://doi.org/10.1016/j.bbrc.2004.09.087
- Andree B, Duprez D, Vorbusch B, Arnold HH, Brand T. BMP-2 induces ectopic expression of cardiac lineage markers and interferes with somite formation in chicken embryos. Mech Dev 1998; 70: 119-31 https://doi.org/10.1016/S0925-4773(97)00186-X
- Ladd AN, Yatskievych TA, Antin PB. Regulation of avian cardiac myogenesis by activin/TGFbeta and bone morphogenetic proteins. Dev Biol 1998; 204: 407-19 https://doi.org/10.1006/dbio.1998.9094
- He X. A Wnt-Wnt situation. Dev Cell 2003; 4: 791-7 https://doi.org/10.1016/S1534-5807(03)00165-5
- Dale TC. Signal transduction by the Wnt family of ligands. Biochem J 1998; 329: 209-23 https://doi.org/10.1042/bj3290209
- Solloway MJ, Harvey RP. Molecular pathways in myocardial development: a stem cell perspective. Cardiovasc Res 2003; 58: 264-77 https://doi.org/10.1016/S0008-6363(03)00286-4
- Tsuji-Takayama K, Inoue T, Ijiri Y, Otani T, Motoda R, Nakamura S, et at. Demethylating agent, 5-azacytidine, reverses differentiation of embryonic stem cells. Biochem Biophys Res Commun 2004; 323: 86-90 https://doi.org/10.1016/j.bbrc.2004.08.052
- Ye NS, Zhang RL, Zhao YF, Feng X, Wang YM, Luo GA. Effect of 5-azacytidine on the protein expression of porcine bone marrow mesenchymal stem cells in vitro. Genomics Proteomics Biolnformatics. 2006; 4: 18-25 https://doi.org/10.1016/S1672-0229(06)60012-0
- Bin Z, Sheng LG, Gang ZC, Hong J, Jun C, Bo Y, et at. Efficient cardiomyocyte differentiation of embryonic stem cells by bone morphogenetic protein-2 combined with visceral endoderm-like cells. Cell Biol Int 2006; 30: 769-76 https://doi.org/10.1016/j.cellbi.2006.05.011
- Wang YX, Qian LX, Liu D, Yao LL, Jiang Q, Yu Z, et al. Bone morphogenetic protein-2 acts upstream of myocyte-specific enhancer factor 2a to control embryonic cardiac contractility. Cardiovasc Res 2007; 74: 290-303 https://doi.org/10.1016/j.cardiores.2007.02.007
- Barron M, Gao M, Lough J. Requirement for BMP and FGF signaling during cardiogenic induction in non-precardiac mesoderm is specific, transient, and cooperative. Dev Dyn 2000; 218: 383-93 https://doi.org/10.1002/(SICI)1097-0177(200006)218:2<383::AID-DVDY11>3.0.CO;2-P
- Alsan BH, Schultheiss TM. Regulation of avian cardiogenesis by FGF8 signaling. Development 2002; 129: 1935-43
- Saga Y, Kitajima S, Miyagawa-Tomita S. Mespl expression is the earliest sign of cardiovascular development. Trends Cardiovasc Med. 2000; 10: 345-52 https://doi.org/10.1016/S1050-1738(01)00069-X
- Ilagan R, Abu-Issa R, Brown D, Yang YP, Jiao K, Schwartz RJ, et al. Fgf8 is required for anterior heart field development. Development. 2006; 133: 2435-45 https://doi.org/10.1242/dev.02408
- Koyanagi M, Bushoven P, Iwasaki M, Urbich C, Zeiher AM, Dimmeler S. Notch signaling contributes to the expression of cardiac markers in human circulating progenitor cells. Circ Res 2007; 101: 1139-45 https://doi.org/10.1161/CIRCRESAHA.107.151381
- Terami H, Hidaka K, Katsumata T, Iio A, Morisaki T. Wntll facilitates embryonic stem cell differentiation to Nkx2.5positive cardiomyocytes. Biochem Biophys Res Commun. 2004; 325: 968-75 https://doi.org/10.1016/j.bbrc.2004.10.103
- Pandur P, Lasche M, Eisenberg LM, Kiihl M. Wnt-11 activation of a non-canonical Wnt signalling pathway is required for cardiogenesis. Nature 2002; 418: 636-41 https://doi.org/10.1038/nature00921